WHO said on Tuesday that it was concerned that the spread of novel coronavirus was being driven by the people in their 20s, 30s and 40s, were unaware that they were infected, by posing a danger to vulnerable groups.The proportion of the younger people among those who are infected had risen globally, putting vulnerable sectors of the population worldwide at risk, including elderly and sick people in densely populated areas with weak health services, said World Health Organization officials this month.
“The epidemic is changing,” WHO Western Pacific regional director, Takeshi Kasai, told in virtual briefing. “People in their 20s, 30s and 40s are increasingly driving the spread. Many are unaware they are infected.”
He also added,”This increases the risk of spillovers to the more vulnerable,” .
According to Reuters data, A surge in new corona virus cases has driven some countries to re-impose the curbs as companies are in race to find a vaccine to fight the virus that has battered economies, have killed more than 770,000 people and infected almost 22 million.
Surges in cases were reported in some countries that have the virus under control, including Vietnam, which for three months recently went without domestic transmission due to its aggressive mitigation efforts.
“What we are observing is not simply a resurgence. We believe it’s a signal that we have entered a new phase of pandemic in the Asia-Pacific,” said Kasai.
He also said that countries were able to reduce disruption to lives and economies by combining the early detection and with responses to manage infections better.
While the mutations had been observed, the WHO saw the virus as “relatively stable”, informed Kasai.
WHO also informed drug manufactures to follow all the necessary research and development steps while creating a vaccine.
Socorro Escalante, technical officer and medicines policy advisor, said the World Health Organization was in coordination with Russia, who became the first country to grant regulatory approval for a COVID-19 vaccine this month. “We hope to get the response in terms of the evidence of this new vaccine,” said Escalante.
